Ainge Gary D, Parlane Natalie A, Denis Michel, Hayman Colin M, Larsen David S, Painter Gavin F
Carbohydrate Chemistry Team, Industrial Research Limited, Lower Hutt, New Zealand.
Bioorg Med Chem. 2006 Nov 15;14(22):7615-24. doi: 10.1016/j.bmc.2006.07.003. Epub 2006 Jul 27.
Phosphatidylinositol mannosides (PIMs) isolated from mycobacteria have been identified as an important class of glycolipids with significant immune modulating properties. We present here the syntheses of phosphatidylinositol dimannoside (PIM2, 1) and phosphatidylinositol tetramannoside (PIM4, 2) and evaluate their adjuvant properties in a transgenic mouse model. The key step in the synthetic methodology for the synthesis of 2 relies on the selective glycosylation of diol 3 with mannosyl donor 11. Both synthetic PIMs were effective at enhancing IFN-gamma when given as adjuvants with a model antigen, with PIM2 being the more active. These data suggest that in this assay the PIM core structure is responsible for the observed biological activity.
从分枝杆菌中分离出的磷脂酰肌醇甘露糖苷(PIMs)已被鉴定为一类重要的糖脂,具有显著的免疫调节特性。我们在此展示了磷脂酰肌醇二甘露糖苷(PIM2,1)和磷脂酰肌醇四甘露糖苷(PIM4,2)的合成,并在转基因小鼠模型中评估了它们的佐剂特性。合成2的合成方法中的关键步骤依赖于二醇3与甘露糖供体11的选择性糖基化。当与模型抗原一起作为佐剂给药时,两种合成的PIMs在增强γ干扰素方面均有效,其中PIM2活性更强。这些数据表明,在该测定中,PIM核心结构是观察到的生物活性的原因。